We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Alan Barry Goldfarb has been assisting clients through the H1B Visa process since 2022.

As of 2022, Alan Barry Goldfarb has succesfully submitted and recieved certification for 450 cases.

Alan Barry Goldfarb is located in Minneapolis, MN, and has represented 75 employers for the H1B Visa Process

470
Cases Handled
450
Cases Certified
95.74%
Approval

Cases Handled by Alan Barry Goldfarb

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-22189-339616 Certified Materials Scientists Colleges Universities And Professional Schools University Of North Dakota 2022
I-200-21182-440882 Certified Chemists Colleges Universities And Professional Schools University Of North Dakota 2021
I-200-23117-973355 Certified Chemists Brick Stone And Related Construction Material Merchant Wholesalers Laticrete International Inc 2023
I-200-22227-417237 Certified Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools University Of North Dakota 2022
I-200-22171-297259 Certified Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools University Of North Dakota 2022
I-200-22038-883714 Certified Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools University Of Minnesota 2022
I-200-21351-773986 Certified Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools University Of North Dakota 2022
I-200-20195-711734 Certified Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools University Of Minnesota 2020
I-200-20135-572050 Certified Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools University Of Minnesota 2020
I-200-21091-189708 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Taiho Oncology Inc 2021